Background: The coronavirus disease (COVID-19) pandemic has led to an unprecedented worldwide burden of disease. However, little is known of the longer-term implications and consequences of COVID-19. One of these may be a COVID-19 associated coagulopathy that can present as a venous thromboembolism (VTE) and further, as multiple paradoxical cerebral emboli. Case presentation: A 51 year old man presented to the emergency department with multiple simultaneous embolic cerebral infarctions 11 months after mild COVID-19. In the subacute phase of the COVID-19 illness the patient developed increasing shortness of breath and was found to have an elevated D-dimer and multiple bilateral segmental pulmonary emboli. He was subsequently treated with ...
A main feature of coronavirus disease 2019 (COVID-19) pathogenesis is the high frequency of thrombos...
Hypercoagulability due to COVID-19 Leads to Sub-massive Bilateral Pulmonary Embolism and Impending P...
BACKGROUND: There is emerging evidence that COVID-19 can trigger thrombosis because of a hypercoagul...
Background: The coronavirus disease (COVID-19) pandemic has led to an unprecedented worldwide burden...
Introduction:The 2019 coronavirus (COVID-19) can cause severe organ dysfunction and death. COVID-19 ...
In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause ...
Abstract Background: Hypercoagulation is one of the striking features of COVID-19. Patients hospita...
Hypercoagulability has been found in patients diagnosed with the novel coronavirus 19 (COVID-19) and...
Background: A systemic coagulation dysfunction has been associated with COVID-19. In this case repor...
Objective : Hospitalized patients with COVID-19 were characterized by a high rate of thromboembolic ...
We present a clinical case of a patient with SARS-CoV-2 infection and respiratory symptoms, complica...
Introduction: Emerging evidence points to an association between severe clinical presentation of COV...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature. This article is licensed under a Cre...
Introduction: Coronavirus Disease 2019 (COVID-19) originating from Wuhan, China, is spreading around...
Background: The coronavirus disease (COVID-19 disease) leads to multiple organ disease, inflammation...
A main feature of coronavirus disease 2019 (COVID-19) pathogenesis is the high frequency of thrombos...
Hypercoagulability due to COVID-19 Leads to Sub-massive Bilateral Pulmonary Embolism and Impending P...
BACKGROUND: There is emerging evidence that COVID-19 can trigger thrombosis because of a hypercoagul...
Background: The coronavirus disease (COVID-19) pandemic has led to an unprecedented worldwide burden...
Introduction:The 2019 coronavirus (COVID-19) can cause severe organ dysfunction and death. COVID-19 ...
In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as the cause ...
Abstract Background: Hypercoagulation is one of the striking features of COVID-19. Patients hospita...
Hypercoagulability has been found in patients diagnosed with the novel coronavirus 19 (COVID-19) and...
Background: A systemic coagulation dysfunction has been associated with COVID-19. In this case repor...
Objective : Hospitalized patients with COVID-19 were characterized by a high rate of thromboembolic ...
We present a clinical case of a patient with SARS-CoV-2 infection and respiratory symptoms, complica...
Introduction: Emerging evidence points to an association between severe clinical presentation of COV...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature. This article is licensed under a Cre...
Introduction: Coronavirus Disease 2019 (COVID-19) originating from Wuhan, China, is spreading around...
Background: The coronavirus disease (COVID-19 disease) leads to multiple organ disease, inflammation...
A main feature of coronavirus disease 2019 (COVID-19) pathogenesis is the high frequency of thrombos...
Hypercoagulability due to COVID-19 Leads to Sub-massive Bilateral Pulmonary Embolism and Impending P...
BACKGROUND: There is emerging evidence that COVID-19 can trigger thrombosis because of a hypercoagul...